• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性骨化性纤维发育不良(FOP)患者的纵向报告移动性评估。

Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).

机构信息

Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; The Center for Research in FOP and Related Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; The Center for Research in FOP and Related Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

出版信息

Bone. 2018 Apr;109:158-161. doi: 10.1016/j.bone.2017.06.005. Epub 2017 Jun 6.

DOI:10.1016/j.bone.2017.06.005
PMID:28600150
Abstract

BACKGROUND

Fibrodysplasia ossificans progressiva (FOP) is a rare, disabling genetic disorder characterized by episodic soft tissue swelling (flare-ups) that leads to progressive heterotopic ossification and restricted joint mobility.

METHODS

Here we present the first longitudinal patient-reported mobility assessment (PRMA) in FOP based on a simple evaluation tool. At initial presentation and follow-up (1-11year span; median: 6 year span), 64 patients (36 females; 28 males) with classic FOP completed a questionnaire designed to rapidly assess mobility at 15 sites (three axial; six upper limb, and six lower limb). In order to validate this instrument, twenty-one of 64 patients (33%) underwent a cumulative analogue joint involvement scale (CAJIS) evaluation by two physicians within six months of their second self-assessment.

RESULTS

We found that: 1) mobility changes were episodic and regional, occurring first in the neck and trunk, followed by the upper limbs and finally the lower limbs; 2) interval improvements in mobility did occur, most notably in the lower limbs (18%), and less so in the upper limbs (12%) and trunk (3%), and 3) patient-reported mobility assessments correlate highly (R=0.81) with physician-reported CAJIS evaluations.

CONCLUSION

This is the first longitudinal PRMA in FOP and provides a simple and valid tool that can be used in the design and evaluation of clinical trials in this progressively disabling disease.

摘要

背景

纤维性骨发育不良(FOP)是一种罕见的、使人丧失能力的遗传性疾病,其特征为偶发性软组织肿胀(发作),导致进行性异位骨化和关节活动受限。

方法

在这里,我们提出了第一个基于简单评估工具的 FOP 患者报告的流动性评估(PRMA)的纵向研究。在初次就诊和随访(1-11 年,中位数:6 年)中,64 例经典 FOP 患者(36 名女性;28 名男性)完成了一项问卷,旨在快速评估 15 个部位的流动性(三个轴向,六个上肢,六个下肢)。为了验证该仪器,在 64 例患者中的 21 例(33%)在第二次自我评估后六个月内,由两位医生进行累积模拟关节受累评分(CAJIS)评估。

结果

我们发现:1)流动性变化呈间歇性和区域性,首先发生在颈部和躯干,然后是上肢,最后是下肢;2)流动性的间隔改善确实发生了,尤其是在下肢(18%),而上肢(12%)和躯干(3%)较少;3)患者报告的流动性评估与医生报告的 CAJIS 评估高度相关(R=0.81)。

结论

这是第一个 FOP 的纵向 PRMA,并提供了一种简单有效的工具,可以用于该进行性致残疾病的临床试验设计和评估。

相似文献

1
Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).进行性骨化性纤维发育不良(FOP)患者的纵向报告移动性评估。
Bone. 2018 Apr;109:158-161. doi: 10.1016/j.bone.2017.06.005. Epub 2017 Jun 6.
2
A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).进行性骨化性纤维发育不良(FOP)的累积模拟关节受累量表(CAJIS)
Bone. 2017 Aug;101:123-128. doi: 10.1016/j.bone.2017.04.015. Epub 2017 Apr 29.
3
Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.纤维性骨发育不良进展性的自然史:注释基线表型的横断面分析。
Orphanet J Rare Dis. 2019 May 3;14(1):98. doi: 10.1186/s13023-019-1068-7.
4
The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.进行性骨化性纤维发育不良(FOP)发作的自然史:一项全面的全球评估。
J Bone Miner Res. 2016 Mar;31(3):650-6. doi: 10.1002/jbmr.2728. Epub 2015 Nov 14.
5
Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.纤维性骨发育不良进展性的影像学评估:定性、定量和可疑。
Bone. 2018 Apr;109:147-152. doi: 10.1016/j.bone.2017.08.011. Epub 2017 Aug 16.
6
Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.成骨不全性骨形成不全进展期患者中急性和慢性雷帕霉素的应用:两例报告。
Bone. 2018 Apr;109:281-284. doi: 10.1016/j.bone.2017.12.011. Epub 2017 Dec 11.
7
Fibrodysplasia Ossificans Progressiva进行性骨化性纤维发育不良
8
Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.大多数纤维性骨发育不良性骨化性肌炎患者的骨折经非手术治疗后愈合,且很少出现发作、异位骨化和活动度丧失。
Clin Orthop Relat Res. 2023 Dec 1;481(12):2447-2458. doi: 10.1097/CORR.0000000000002672. Epub 2023 May 8.
9
Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.帕罗维罗汀可抑制携带人类ACVR1(R206H)突变的进行性骨化性纤维发育不良(FOP)小鼠的异位骨化,并维持肢体活动能力和生长。
J Bone Miner Res. 2016 Sep;31(9):1666-75. doi: 10.1002/jbmr.2820. Epub 2016 Mar 12.
10
Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP).纤维性骨发育不良伴进行性骨化性纤维发育不良(FOP)的关节特异性功能障碍风险。
Bone. 2018 Apr;109:124-133. doi: 10.1016/j.bone.2017.06.009. Epub 2017 Jun 13.

引用本文的文献

1
A systematic literature review of the impact and measurement of mobility impairment in rare bone diseases.罕见骨病中活动能力障碍的影响及测量的系统文献综述。
Ther Adv Musculoskelet Dis. 2025 Aug 21;17:1759720X251369963. doi: 10.1177/1759720X251369963. eCollection 2025.
2
MyD88 Is Not Required for Muscle Injury-Induced Endochondral Heterotopic Ossification in a Mouse Model of Fibrodysplasia Ossificans Progressiva.在进行性骨化性纤维发育不良小鼠模型中,肌肉损伤诱导的软骨内异位骨化不需要MyD88。
Biomedicines. 2021 Jun 1;9(6):630. doi: 10.3390/biomedicines9060630.
3
Methods for the reliable induction of heterotopic ossification in the conditional mouse.
条件性小鼠异位骨化的可靠诱导方法。
J Musculoskelet Neuronal Interact. 2020 Mar 3;20(1):149-159.